Sramana Mitra: We’ve done vertical industry-specific problems and functional problems in this discussion so far. Could you discuss a platform company that you have invested in?
>>>Sramana Mitra: Let’s do quickly a few other companies and just focus on the problems they’re solving. We don’t need to go into the stages, but let’s just get a sample of the problems they’re solving.
>>>Sramana Mitra: So if you are doing a pre-seed round in AI, what do you ask to see in the company? Do you see an MVP? Do you see just a concept? What stage are you investing in?
>>>Jukka Alanen, Managing Partner at Rebellion Ventures, discusses his portfolio, investment thesis and related trends.
>>>Jishnu Bhattacharjee, Managing Partner at Nexus Venture Partners, has been investing in AI startups for over a decade. This is an excellent and insightful discussion about his AI investment thesis.
Podcast: Play in new window | Download
Subscribe: Apple Podcasts | Android | Google Play | Stitcher | TuneIn | RSS
Sramana Mitra: There’s another factor to consider. There’s this company called Tempus that went public in June this year. I don’t know if you’re tracking them. Tempus is an AI company that focuses on the pharmaceutical industry. It has all kinds of pharmaceutical use cases and healthcare use cases. It doesn’t look like a language model-based solution. It’s an older company, obviously. It already has revenue of over $500 million.
>>>Rajeev Madhavan, Founder and General Partner at Clear Ventures, discusses how he is investing in AI startups and what he is learning from the market.
>>>Sramana Mitra: I think for entrepreneurs listening to this conversation, there are two takeaways that you want to consider. One is, find a platform that you can build on. If you’re building enterprise products or mid-market B2B products, look at a platform called Cohere.
>>>